Steven Cohen acquired 150 Thousand Gilead Sciences shares worth $14.7 Million. That's 0.05% of their equity portfolio (394th largest holding). The first Gilead Sciences trade was made in Q4 2014. Since then Steven Cohen bought shares 25 more times and sold shares on twenty occasions. The stake costed the investor $13.5 Million, netting the investor a gain of 8.8% so far.